Dose-dependent constipation with higher doses of quetiapine: a case series.
Standard
Dose-dependent constipation with higher doses of quetiapine: a case series. / Raedler, Thomas J; Reimer, Jens; Wiedemann, Klaus.
in: INT CLIN PSYCHOPHARM, Jahrgang 22, Nr. 4, 4, 2007, S. 244-246.Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › SCORING: Zeitschriftenaufsatz › Forschung › Begutachtung
Harvard
APA
Vancouver
Bibtex
}
RIS
TY - JOUR
T1 - Dose-dependent constipation with higher doses of quetiapine: a case series.
AU - Raedler, Thomas J
AU - Reimer, Jens
AU - Wiedemann, Klaus
PY - 2007
Y1 - 2007
N2 - Quetiapine is a dopamine D2 and serotonin 5-HT2 antagonist with antipsychotic and mood-stabilizing properties. Recent studies suggest that higher doses of quetiapine combine superior therapeutic efficacy with good tolerability. We present five patients, in whom treatment with higher doses of quetiapine was associated with constipation. Our observations raise the question of dose-dependent constipation under treatment with quetiapine.
AB - Quetiapine is a dopamine D2 and serotonin 5-HT2 antagonist with antipsychotic and mood-stabilizing properties. Recent studies suggest that higher doses of quetiapine combine superior therapeutic efficacy with good tolerability. We present five patients, in whom treatment with higher doses of quetiapine was associated with constipation. Our observations raise the question of dose-dependent constipation under treatment with quetiapine.
M3 - SCORING: Zeitschriftenaufsatz
VL - 22
SP - 244
EP - 246
JO - INT CLIN PSYCHOPHARM
JF - INT CLIN PSYCHOPHARM
SN - 0268-1315
IS - 4
M1 - 4
ER -